Pfizer has acquired the obesity drug developer Metsera. The deal is valued at up to $10 billion. This concludes a…
Browsing: Pfizer obesity drug
Metsera stock surged on Monday after Pfizer announced it will acquire the biotech firm in a multi-billion-dollar deal. The agreement…